<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01588119</url>
  </required_header>
  <id_info>
    <org_study_id>NOAC</org_study_id>
    <nct_id>NCT01588119</nct_id>
  </id_info>
  <brief_title>Register for New Oral Anticoagulants</brief_title>
  <acronym>NOAC</acronym>
  <official_title>Prospective Register Study to Record Safety and Efficacy of New Oral Anticoagulants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>GWT-TUD GmbH</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>GWT-TUD GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients, who are adjusted to a new oral anticoagulant (Dabigatran, Rivaroxaban, Apixaban,
      Edoxaban) in routine treatment will recorded in this register. Within this register a
      characterization of patients (with regard to demography and indication) and therapy (with
      regard to medication, dose and duration) will be done. On basis of defined clinical relevant
      end points the long-term efficacy and safety will be evaluated.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">3500</enrollment>
  <condition>Anticoagulation Treatment</condition>
  <arm_group>
    <arm_group_label>Dabigatran</arm_group_label>
    <description>in atrial fibrillation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Rivaroxaban</arm_group_label>
    <description>in atrial fibrillation and VTE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Apixaban</arm_group_label>
    <description>in atrial fibrillation and VTE</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Edoxaban</arm_group_label>
    <description>in atrial fibrillation</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        patients in clinical routine
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  indication for treatment with long term anticoagulation

          -  initial adjustment or change to nex oral anticoagulant within routine treatment

          -  indication for treatment with long term anticoagulation within the register:

          -  permanent anticoagulation in arterial fibrillation

          -  intended anticoagulation in acute venous thromboembolism for min. 3 months

          -  other anticoagulation for min. 3 months within the approved indication

        Exclusion Criteria:

          -  missing Informed Consent Form

          -  missing phone number for telephone follow up

          -  contraindication for therapy with new oral anticoagulant (Dabigatran, Rivaroxaban,
             Apixaban, Edoxaban) according to Summary of Product Characteristics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Beyer-Westendorf, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>study site at Universitätsklinikum Dresden on behalf of GWT-TUD GmbH</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jan Beyer-Westendorf, MD</last_name>
    <phone>+49 351 458</phone>
    <phone_ext>3659</phone_ext>
    <email>jan.beyer@uniklinikum-dresden.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Universitätsklinikum Dresden on behalf of GWT-TUD GmbH</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Beyer-Westendorf, MD</last_name>
      <phone>0049 0351 458</phone>
      <phone_ext>3659</phone_ext>
      <email>jan.beyer@uniklinikum-dresden.de</email>
    </contact>
    <investigator>
      <last_name>Jan Beyer-Westendorf, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2012</study_first_submitted>
  <study_first_submitted_qc>April 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2012</study_first_posted>
  <last_update_submitted>January 19, 2017</last_update_submitted>
  <last_update_submitted_qc>January 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anticoagulants</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

